NASDAQ: BTMD - biote Corp.

Rentabilidad a seis meses: -3.25%
Sector: Healthcare

Calendario de promoción biote Corp.


Acerca de la empresa

biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irvine, Texas.


EBITDA 0.0243
EV/EBITDA 1.51
IPO date 2021-04-28
ISIN US0906831039
Industry Health Care Equipment & Supplies
P/BV 17.99
P/E 2.28
P/S 0.5325
Sector Health Care
Валюта usd
Валюта отчета usd
Выручка 0.11
Сайт https://biote.com
Цена ао 5.9
Число акций ао 0.02571 млрд
Cambio de precio por día: 0% (5.36)
Cambio de precio por semana.: +1.9% (5.26)
Cambio de precio por mes: -8.53% (5.86)
Cambio de precio en 3 meses.: -31.63% (7.84)
Cambio de precio en seis meses: -3.25% (5.54)
Cambio de precio por año: +1.71% (5.27)
Cambio de precio en 3 años.: -45.14% (9.77)
Cambio de precio desde principios de año.: +7.2% (5)

Subestimación

Nombre Significado Calificación
P/S 0.7046 10
P/BV -3.57 0
P/E 39.39 4
EV/EBITDA 3.39 10
Total: 7

Eficiencia

Nombre Significado Calificación
ROA, % 2.14 1
ROE, % -11.28 0
Total: 1.5

Dividendos

Nombre Significado Calificación
Div yield, % 0 0
DSI 0 0
Total: 0.5643

Deber

Nombre Significado Calificación
Debt/EBITDA 2.45 6
Total: 6.8

Impulso de crecimiento

Nombre Significado Calificación
Rentabilidad Revenue, % 68.51 8
Rentabilidad Ebitda, % 90.19 9
Rentabilidad EPS, % -95.41 0
Total: 3.6

Instituciones Volumen Compartir, %
325 Capital Llc 3766666 11.86
Bandera Partners LLC 1832732 5.77
Vanguard Group Inc 1419529 4.47
Wasatch Advisors LP 1072781 3.38
Blackrock Inc. 972597 3.06
Kanen Wealth Management LLC 837643 2.64
Boston Partners 829927 2.61
SW Investment Management, LLC 675000 2.13
Geode Capital Management, LLC 472190 1.49
State Street Corporation 255279 0.8

ETF Compartir, % Rentabilidad del año, % Dividendos, %
Dimensional U.S. Core Equity 2 ETF 0.00017 30.755198832543 1.47098
WisdomTree U.S. SmallCap Fund 0.01603 8.3066022311694 1.80258
First Trust Dow Jones Select MicroCap Index Fund 0.32219 26.184578018465 1.56612
Franklin U.S. Small Cap Multifactor Index ETF 0.01574 9.2362903733552 1.90721
ProShares Hedge Replication ETF 0.00098 5.9237999659878 1.47892
iShares Micro-Cap ETF 0.04176 11.903735012508 1.54048
iShares Russell 2000 Growth ETF 0.01107 38.042556988 0.6026
Hartford Multifactor Small Cap ETF 0.21224 26.312925170068 2.59467
Royce Quant Small‑Cap Quality Value ETF 0.29333 21.829200353285 1.62596
ProShares UltraPro Russell2000 0.00352 89.821266282945 1.47873
Vanguard Russell 3000 ETF 0 31.87314172448 1.43817
Vanguard Russell 2000 Growth ETF 0.01 14.283381416363 0.60264
Vanguard Russell 2000 ETF 0.01 10.653723273532 1.48801



Supervisor Título profesional Pago año de nacimiento
Mr. Marc D. Beer Executive Chairman 470.18k 1965 (59 años)
Ms. Teresa S. Weber CEO & Director 1.06M 1953 (71 año)
Ms. Mary Elizabeth Conlon VP of Business Development, General Counsel & Corporate Secretary 552.36k 1981 (43 año)
Mr. Richard Kevin Key Chief Digital Officer N/A 1971 (53 año)
Mr. Jade Beutler Head of Nutraceuticals N/A 1963 (61 año)
Mr. James Elliott Gibbs II Chief People Officer N/A
Mr. Robert C. Peterson Chief Financial Officer N/A 1977 (47 años)
Mr. John J. Olsen Chief Information Officer N/A 1957 (67 años)
Dr. Cory Rice D.O. Chief Clinical Advisor & Member of Medical Advisory Board

DIRECCIÓN: United States, Irving. TX, 1875 West Walnut Hill Lane - abrir en mapas de google, abrir mapas de Yandex
Sitio web: https://biote.com